185 related articles for article (PubMed ID: 32278965)
1. Small Bowel Adenocarcinomas: Impact of Location on Survival.
Lee TC; Wima K; Morris MC; Winer LK; Sussman JJ; Ahmad SA; Wilson GC; Patel SH
J Surg Res; 2020 Aug; 252():116-124. PubMed ID: 32278965
[TBL] [Abstract][Full Text] [Related]
2. Clinical Outcomes of Small Bowel Adenocarcinoma.
Akce M; Jiang R; Zakka K; Wu C; Alese OB; Shaib WL; Behera M; El-Rayes BF
Clin Colorectal Cancer; 2019 Dec; 18(4):257-268. PubMed ID: 31606297
[TBL] [Abstract][Full Text] [Related]
3. Adenocarcinoma of the small bowel: presentation, prognostic factors, and outcome of 217 patients.
Dabaja BS; Suki D; Pro B; Bonnen M; Ajani J
Cancer; 2004 Aug; 101(3):518-26. PubMed ID: 15274064
[TBL] [Abstract][Full Text] [Related]
4. Treatment and Survival of Small-bowel Adenocarcinoma in the United States: A Comparison With Colon Cancer.
Young JI; Mongoue-Tchokote S; Wieghard N; Mori M; Vaccaro GM; Sheppard BC; Tsikitis VL
Dis Colon Rectum; 2016 Apr; 59(4):306-15. PubMed ID: 26953989
[TBL] [Abstract][Full Text] [Related]
5. Clinical features, treatment, and prognosis of different histological types of primary small bowel adenocarcinoma: A propensity score matching analysis based on the SEER database.
Zhou YW; Xia RL; Chen YY; Ma XL; Liu JY
Eur J Surg Oncol; 2021 Aug; 47(8):2108-2118. PubMed ID: 33849741
[TBL] [Abstract][Full Text] [Related]
6. Adenocarcinoma of the small intestine: a multi-institutional study of 197 surgically resected cases.
Chang HK; Yu E; Kim J; Bae YK; Jang KT; Jung ES; Yoon GS; Kim JM; Oh YH; Bae HI; Kim GI; Jung SJ; Gu MJ; Kim JY; Jang KY; Jun SY; Eom DW; Kwon KW; Kang GH; Park JB; Hong S; Lee JS; Park JY; Hong SM;
Hum Pathol; 2010 Aug; 41(8):1087-96. PubMed ID: 20334897
[TBL] [Abstract][Full Text] [Related]
7. Malignant small bowel neoplasms: histopathologic determinants of recurrence and survival.
Cunningham JD; Aleali R; Aleali M; Brower ST; Aufses AH
Ann Surg; 1997 Mar; 225(3):300-6. PubMed ID: 9060587
[TBL] [Abstract][Full Text] [Related]
8. The characteristics and outcomes of small bowel adenocarcinoma: a multicentre retrospective observational study.
Sakae H; Kanzaki H; Nasu J; Akimoto Y; Matsueda K; Yoshioka M; Nakagawa M; Hori S; Inoue M; Inaba T; Imagawa A; Takatani M; Takenaka R; Suzuki S; Fujiwara T; Okada H
Br J Cancer; 2017 Nov; 117(11):1607-1613. PubMed ID: 28982111
[TBL] [Abstract][Full Text] [Related]
9. Prognostic relevance of lymph node ratio and total lymph node count for small bowel adenocarcinoma.
Tran TB; Qadan M; Dua MM; Norton JA; Poultsides GA; Visser BC
Surgery; 2015 Aug; 158(2):486-93. PubMed ID: 26013988
[TBL] [Abstract][Full Text] [Related]
10. An Examination of Lymph Node Sampling as a Predictor of Survival in Resected Node-Negative Small Bowel Adenocarcinoma: a SEER Database Analysis.
Thiessen M; Lee-Ying RM; Monzon JG; Tang PA
J Gastrointest Cancer; 2020 Mar; 51(1):280-288. PubMed ID: 31111426
[TBL] [Abstract][Full Text] [Related]
11. Is there a role for adjuvant therapy in resected adenocarcinoma of the small intestine.
Overman MJ; Kopetz S; Lin E; Abbruzzese JL; Wolff RA
Acta Oncol; 2010 May; 49(4):474-9. PubMed ID: 20397775
[TBL] [Abstract][Full Text] [Related]
12. Adjuvant chemotherapy versus chemoradiotherapy in the management of patients with surgically resected duodenal adenocarcinoma: A propensity score-matched analysis of a nationwide clinical oncology database.
Ecker BL; McMillan MT; Datta J; Lee MK; Karakousis GC; Vollmer CM; Drebin JA; Fraker DL; Roses RE
Cancer; 2017 May; 123(6):967-976. PubMed ID: 28263387
[TBL] [Abstract][Full Text] [Related]
13. Tumor Microenvironmental Prognostic Risk in Primary Operable Small Intestinal Adenocarcinoma.
Jun SY; Lee EJ; Hong SM; Jung ES; Chung JY
Am J Surg Pathol; 2021 Jul; 45(7):917-929. PubMed ID: 33443865
[TBL] [Abstract][Full Text] [Related]
14. Clinicopathologic analysis of gastrointestinal stromal tumors in duodenum and small intestine.
Han IW; Jang JY; Lee KB; Kang MJ; Kwon W; Park JW; Chang YR; Lee HJ; Park KJ; Kim SW
World J Surg; 2015 Apr; 39(4):1026-33. PubMed ID: 25270345
[TBL] [Abstract][Full Text] [Related]
15. Adenocarcinoma of the small intestine.
Ouriel K; Adams JT
Am J Surg; 1984 Jan; 147(1):66-71. PubMed ID: 6691554
[TBL] [Abstract][Full Text] [Related]
16. Duodenal localization is a negative predictor of survival after small bowel adenocarcinoma resection: A population-based, propensity score-matched analysis.
Wilhelm A; Galata C; Beutner U; Schmied BM; Warschkow R; Steffen T; Brunner W; Post S; Marti L
J Surg Oncol; 2018 Mar; 117(3):397-408. PubMed ID: 29044591
[TBL] [Abstract][Full Text] [Related]
17. Prognostic relevance of programmed death-ligand 1 expression and microsatellite status in small bowel adenocarcinoma.
Klose J; Lasitschka F; Horsch C; Strowitzki MJ; Bruckner T; Volz C; Schmidt T; Schneider M
Scand J Gastroenterol; 2020 Mar; 55(3):321-329. PubMed ID: 32191146
[No Abstract] [Full Text] [Related]
18. Trends in incidence, treatment and survival of small bowel adenocarcinomas between 1999 and 2013: a population-based study in The Netherlands.
Legué LM; Bernards N; Gerritse SL; van Oudheusden TR; de Hingh IH; Creemers GM; Ten Tije AJ; Lemmens VE
Acta Oncol; 2016; 55(9-10):1183-1189. PubMed ID: 27170100
[TBL] [Abstract][Full Text] [Related]
19. Impact of Tumor Location on Patient Outcomes in Small Bowel Cancers.
Yu IS; Al-Hashami Z; Chapani P; Speers C; Davies JM; Lim HJ; Renouf DJ; Gill S; Stuart HC; Loree JM
Clin Colorectal Cancer; 2022 Jun; 21(2):107-113. PubMed ID: 34972663
[TBL] [Abstract][Full Text] [Related]
20. The impact of stage, grade, and mucinous histology on the efficacy of systemic chemotherapy in adenocarcinomas of the appendix: Analysis of the National Cancer Data Base.
Asare EA; Compton CC; Hanna NN; Kosinski LA; Washington MK; Kakar S; Weiser MR; Overman MJ
Cancer; 2016 Jan; 122(2):213-21. PubMed ID: 26506400
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
